Telangana Launches Life Sciences Policy
Analysis based on 8 articles · First reported Jan 21, 2026 · Last updated Jan 21, 2026
The launch of India — Telangana's Next-Gen Life Sciences Policy 2026–30 is expected to significantly boost the biotechnology, pharmaceuticals, and medical devices industries in India — Telangana. The policy's focus on attracting $25 billion in investments and creating 500,000 jobs could lead to increased foreign direct investment and job growth, positively impacting the regional economy and potentially the broader Indian market.
India — Telangana has launched its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum Annual Meeting in Switzerland — Davos. The policy, unveiled by Chief Minister Revanth Reddy, aims to attract $25 billion in investments and create 500,000 new jobs by 2030, positioning India — Telangana among the top five global life sciences clusters. It marks a strategic shift towards value-driven, innovation-powered growth, emphasizing frontier R&D, advanced therapeutics, and sustainable bio-manufacturing. Key initiatives include recognising R&D units as industrial enterprises for incentives, creating a Green Pharma City, developing 10 'pharma villages', and establishing a Life Sciences Innovation Fund with an initial corpus of ₹100 crore. The policy also focuses on talent development through the proposed India — Telangana School of Life Sciences and strengthening existing infrastructure like Genome Valley and Medical Devices Park. Global companies such as Amgen, Sanofi, Bristol Myers Squibb, and Eli Lilly and Company already have a presence in Hyderabad, reflecting confidence in India — Telangana's scientific talent and innovation-ready infrastructure.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard